Paris, France and Camberley, UK – 2 August 2019 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces that SP Angel Corporate Finance LLP will be the sole broker to the Company with immediate effect. http://novacyt.com/wp-content/uploads/2019/08/Novacyt-Change-of-Adviser-FR-02.08.19.pdf
Visit PageCategory: Uncategorized
Liquidity Agreement Monthly Update and Total Voting Rights
Paris, France and Camberley, UK – 1 Aug 2019 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, today announces its monthly update in relation to ordinary shares traded under its ongoing liquidity agreement with Invest Securities SA (the “Liquidity Agreement”). The Liquidity Agreement is governed by French law and is further summarised
Visit PageRapport d’activité du premier semestre Croissance de 12% du chiffre d’affaires à 7,2 millions d’euros
Paris, France et Camberley, Royaume-Uni – 30 juillet 2019 – Novacyt (ALTERNEXT : ALNOV ; AIM : NCYT), spécialiste mondial des diagnostics cliniques, publie ce jour un rapport d’activité non-audité pour la période de six mois close le 30 juin 2019. http://novacyt.com/wp-content/uploads/2019/07/Novacyt-Chiffre-daffaires-semestriels-FINAL.pdf
Visit Page